NEW FORMS OF N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-1-PROPYL-4-(2,2,2-TRIFLUOROETHOXY)-1H-PYRAZOLE-3-CARBOXAMIDE HYDROCHLORIDE

Abstract: the present invention relates to new forms of inhibitors of axl/mer receptor tyrosine kinase and csf1r (colony stimulating factor 1 receptor), and in particular to new forms of n-(5-((6,7-dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-1-propyl-4-(2,2,2-trifluoro-ethoxy)-1h-pyrazole-3-carboxamide hydrochloride.

Inventor(s): Kiyean NAM, Jaeseung KIM, Borami JEON

CPC Classification: C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250188058